Faculty Opinions recommendation of Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles.

2011 ◽  
Author(s):  
Livio Pagano ◽  
Morena Caira
Keyword(s):  
Stem Cell ◽  
Invasive Aspergillosis ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Hematologic Malignancy ◽  
Outcome Analysis ◽  
Cell Transplant ◽  
Hematopoietic Stem ◽  
Transplant Patients

scholarly journals The Role of Screening Sinus Computed Tomography in Pediatric Hematopoietic Stem Cell Transplant Patients

2015 ◽  
Vol 39 (2) ◽  
pp. 228-231 ◽  
Author(s):  
Carlos A. Zamora ◽  
Avi G. Oppenheimer ◽  
Hema Dave ◽  
Heather Symons ◽  
Thierry A. G. M. Huisman ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Hematopoietic Stem ◽  
Transplant Patients

P013 Role of next generation sequencing in HLA typing of hematopoietic stem cell transplant patients: Two case reports

2019 ◽  
Vol 80 ◽  
pp. 63
Author(s):  
Tiffany R. Baker ◽  
Susana O. Infante ◽  
Eric D. Garabiles ◽  
Rodrigo O. Santiago ◽  
Yuri L. Robinson ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Case Reports ◽  
Hla Typing ◽  
Cell Transplant ◽  
Hematopoietic Stem ◽  
Transplant Patients ◽  
Generation Sequencing

scholarly journals Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009

2011 ◽  
Vol 55 (11) ◽  
pp. 5018-5021 ◽  
Author(s):  
Sarah P. Hammond ◽  
Lindsey R. Baden ◽  
Francisco M. Marty
Keyword(s):  
Stem Cell ◽  
Liposomal Amphotericin ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Treatment Approach ◽  
Hematologic Malignancy ◽  
Single Agent ◽  
Cell Transplant ◽  
Hematopoietic Stem ◽  
Transplant Patients

ABSTRACTMortality due to mucormycosis is high. We assessed clinical characteristics and mortality among stem cell transplant and hematologic malignancy patients diagnosed with mucormycosis from 2001 to 2009. Thirty patients were diagnosed with probable or proven mucormycosis during the study. Twenty-six were diagnosed premortem, and most were treated with liposomal amphotericin B single-agent antifungal therapy initially. While the initial antifungal and surgical treatment approach remained stable throughout the study period, 6-week mortality significantly declined over time (67% in 2001 to 2003 versus 45% in 2004 to 2006 versus 20% in 2007 to 2009 [P= 0.04]), as did 12-week mortality (78% in 2001 to 2003 versus 55% in 2004 to 2006 versus 20% in 2007 to 2009 [P= 0.01]).

Sign in / Sign up

Export Citation Format

Share Document